Wed, December 2, 2020
Tue, December 1, 2020
Mon, November 30, 2020
Sun, November 29, 2020
Fri, November 27, 2020
Wed, November 25, 2020
Tue, November 24, 2020
Mon, November 23, 2020
Fri, November 20, 2020
Thu, November 19, 2020
Wed, November 18, 2020
Tue, November 17, 2020

Liisa Bayko Initiated (TBPH) at Buy and Held Target at $30 on, Nov 24th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-30-on-nov-24th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Liisa Bayko of Evercore ISI Group, Initiated "Theravance Biopharma, Inc." (TBPH) at Buy and Held Target at $30 on, Nov 24th, 2020.

Liisa has made no other calls on TBPH in the last 4 months.



There are 3 other peers that have a rating on TBPH. Out of the 3 peers that are also analyzing TBPH, 0 agree with Liisa's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Liisa


  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $35 on, Friday, November 6th, 2020
  • Vikram Purohit of "Morgan Stanley" Upgraded from Hold to Buy on, Wednesday, October 14th, 2020
  • Tyler Van Buren of "Piper Sandler" Maintained at Buy with Decreased Target to $30 on, Monday, August 10th, 2020

Publication Contributing Sources